Increased uridine kinase (ATP: Uridine 5′-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors

Cancer Biochemistry Biophysics

Volumn 16, Issue 1, 1997, Pages 1-15

  Shen, Fei ^a   Look, Katherine Y ^a   Yeh, Y Albert ^a   Weber, George ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIDINE KINASE;

ANIMAL; ARTICLE; BONE MARROW; CELL CULTURE; COMPARATIVE STUDY; ENZYME STABILITY; ENZYMOLOGY; FEMALE; HALF LIFE TIME; HUMAN; KINETICS; LIVER; LIVER TUMOR; MALE; METABOLISM; OVARY; OVARY TUMOR; RAT; SPRAGUE DAWLEY RAT; STARVATION; TEMPERATURE; WISTAR RAT;

ANIMALS; BONE MARROW; ENZYME STABILITY; FEMALE; HALF-LIFE; HUMANS; KINETICS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OVARIAN NEOPLASMS; OVARY; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; STARVATION; TEMPERATURE; TUMOR CELLS, CULTURED; URIDINE KINASE;

EID: 0032083247     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ahmed N. K. (1984). Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinomas, and xenografts. Cancer, 54, 1370.
2. Aoki T., H. P. Morris and G. Weber (1982). Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues. J Biol. Chem., 257, 432.
3. Bresnick E., S. S. Williams and H. Mosse (1967). Rates of turnover of deoxythymidine kinase and of its template RNA in regenerating and control liver. Cancer Res., 27, 469.
4. Cihak A. and B. Rada (1676). Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review) Neoplasma. 23, 233.
5. Cysyk R. L., N. Malinowski, V. Marquez and D. Zaharevitz (1995). Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo. Biochem. Pharmacol., 49, 203.
6. Denton J. E., M. S. Lui, T. Aoki, J. Sebolt, E. Takeda, J. N. Eble, J Glover and G. Weber (1982). Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas. Cancer Res., 42, 1176.
7. Fox M., J M Boyle and A. R. Kinsella (1991) Nucleoside salvage and resistance to antimetabolite anticancer agents. Brit. J. Cancer., 64(3), 428.
8. Greengard O., J. F. Head and S. L. Goldberg (1980). Uridine kinase, adenylate kinase, and guanase in human lung tumors. Cancer Res., 40, 2295.
9. Hogans A. F , G. Guroff and S. Udenfriend (1969). Studies on the origin of pyrimidines for biosynthesis of neural RNA in the rat. J. Neurochem., 18, 1699.
10. Karle J. M , L. W. Anderson and R. L. Cysyk (1984). Effect of plasma concentration of undine on pyrimidine biosynthesis in cultured L1210 cells. J. Biol. Chem., 259, 67.
11. Krystal G. and T. E Webb (1971). Multiple forms of uridine kinase in normal and neoplastic rat liver. Biochem. J., 124, 943.
12. Look K. Y , G. P Sutton, Y. Natsumeda, J. N. Eble, F. B. Stehman, C. E. Ehrlich, E. Olah, N. Prajda, P. Bosze, S.Eckhardt and G.Weber (1990). Inhibition by tiazofurin of inosine 5′-phosphate dehydrosenase activity in extracts of ovarian carcinomas. Gynecologic Oncol., 47, 66.
13. Lowry O H., N. J. Rosebrough, A L. Farr and R. J. Randall (1951). Protein measurement with the Folin phenol reagent. J. Biol Chem., 193, 265.
14. Olah E. and G. Weber (1979). Giesma-banding karyotype of rat hepatomas of different growth rates Cancer Res., 39, 1708.
15. Orice N. C. and L. Stevens (1989). Enzyme turnover. In: Fundamentals of Enzymology. Ed. 2. p. 433. Oxford, U. K.: Oxford Univ. Press.
16. Paterson A. R. P., E. Y. Lau, E. Dahlig and C. E. Cass (1980). A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine? Mol. Pharmacol., 18, 40.
17. Plagemann P. G. W. and M. Behrens (1976). Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095). Cancer Res., 36. 3807.
18. Prajda N., Y. Hata, M. Abonyi, R. L. Singhal and G. Weber (1993). Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow. Cancer Res., 53, 5982.
19. Singhal R. L., N. Prajda, Y. A. Yeh and G. Weber (1994). 1-phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme. Cancer Res., 54, 5574.
20. Skoïd O. (1960). Enzymes of uracil metabolism in tissues with different growth characteristics. Biochim. Biophys. Acta. 44, 1.
21. Weber G. (1983). Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res., 43, 3466.
22. Weber G. and A. Cantero (1957). Studies on hormonal factors influencing hepatic glucose-6-phosphatase. Endocrinology, 61, 701.
23. Weber G., E. Olah, J. E. Denton, M. S. Lui, E. Takeda, D. Y. Tzeng and J. Ban (1978). Dynamics of modulation of biochemical programs in cancer cells. Advan. Enzyme Regul., 16, 3.
24. Weber G. and N. Prajda (1984). Targeted and non-targeted actions of anti-cancer drugs. Advan. Enzyme Regul., 34, 71.
25. Weber G., N. Prajda, H. Y. Yang, Y A. Yeh, F. Shen, R. L. Singhal, M. Herenyiova and K. Y. Look (1996). Current issues in regulation of signal transduction. Advan. Enzyme Regul , 36, 33.
26. Zhen Y. S., M. S. Lui and G. Weber (1983). Effects of acivicin and dipyridamole on hepatoma 3924A cells. Cancer Res., 43, 1616.